Yes.
There are examples of patients who have gone abroad and come back with infections, because their immune systems were compromised and the treatments being administered were not clear.
I would say that it is imperative that we develop a broad structure that allows rapid assessment of these therapies that the public can have good confidence in. Then we will not have the tourism that could occur.
I think that will be impacting the health care system in a big way, and all of the provinces are going to be mired in having to evaluate untested therapies. We have seen the problems that arise, such as the procedure for multiple sclerosis that's causing a lot of heartache and difficulties for the regulatory bodies.